The risks of prostate cancer detection by transrectal ultrasound guide biopsy in Thai men with abnormal prostatic-specific antigen or abnormal digital rectal examination

Journal of the Medical Association of Thailand

Volumn 83, Issue 12, 2000, Pages 1519-1524

  Leewansangtong, Sunai ^a   Ratanarapee, Samrerng ^b   Soontrapa, Suchai ^a   Tantiwong, Anupan ^a   Nualyong, Chaiyong ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Prostate; Prostatic Carcinoma; Prostatic Specific Antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY; BLOOD; ECHOGRAPHY; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PHYSICAL EXAMINATION; PROSTATE TUMOR; PROSTATECTOMY;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; HUMANS; MALE; MIDDLE AGED; PHYSICAL EXAMINATION; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 0034576809     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Soontrapa S, Tantiwong A, Panawattanakul S, et al. Prostate carcinoma at Siriraj Hospital. Siriraj Hos Gaz 1997; 49: 107-13.
2. Soontrapa S, Tantiwong A, Leewansangtong S, et al. Five-year follow-up of prostate cancer in Siriraj Hospital. J Med Assoc Thai 2000; 83: 236-42.
3. Leewansangtong S, Soontrapa S, Tantiwong A. Is prostate-specific antigen still the best tumor marker for prostate cancer. J Med Assoc Thai 1999; 82: 1034-40.
4. Cooner WH, Mosley BR, Rutherford CL Jr, et al. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 1990; 143: 1146-54.
5. Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994; 151: 1283-90.
6. Crawford ED, Leewansangtong S, Goktas S, et al. Efficiency of prostate-specific antigen and digital rectal examination in screening, using 4.0 ng/ml and age-specific reference range as a cutoff for abnormal values. Prostate 1999; 38: 296-302.
7. Schambeck CM. Evaluation of the COBAS CORE Immunoassay for measuring prostate-specific antigen (PSA)-multi-centre study results. The PSA Study Group. Eur J Clin Chem Clin Biochem 1995; 33: 541-7.
8. Hodge KK, McNeal JE, Terris MK, et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989; 142: 71-5.
9. SPSS Inc. Chicago, Illinois.
10. Leewansangtong S, Goktas S, Lepoff R, et al. Comparability of serum prostate-specific antigen measurement between the hybritech Tandem-R and Abbott AxSYM assays. Urology 1998; 52: 467-9.
11. Epstein JI, Pizov G, Walsh PC. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 1993; 71: 3582-93.
12. Partin AW, Pound CR, Clemens JQ, et al. Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol Clin North Am 1993; 20: 713-25.